Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats

被引:61
作者
Fong, LYY
Zhang, L
Jiang, YB
Farber, JL
机构
[1] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
关键词
D O I
10.1093/jnci/dji006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Cancer of the upper aerodigestive tract, including esophageal and tongue carcinomas, is a major cause of cancer deaths worldwide. Esophageal and tongue cancers have both been associated with dietary zinc deficiency (ZD), and cyclooxygenase (COX-2) is often overexpressed in these cancers. Using rat models, we examined whether zinc regulates COX-2 expression in these cancers. Method: Expression of COX-2 protein and mRNA in rat lingual and esophageal epithelia in control (zinc sufficient [ZS]) rats, during ZD, and after intragastric zinc replenishment (ZR) were determined by immunoblotting, immunohistochemistry, and real-time quantitative polymerase chain reaction. COX-2 gene expression, cell proliferation, and apoptosis were analyzed in ZD, ZR, and ZD rats treated with the COX-2 inhibitors celecoxib and indomethacin. Tumor development in ZD rats treated by continuous exposure to the carcinogen 4-nitroquinoline 1 oxide (NQO), which causes tongue tumors in rats, was compared with those in NQO-treated ZS rats. Statistical tests were two-sided. Results: The esophagus and tongue of ZD rats were hyperplastic and expressed COX-2 protein and mRNA at 8- to 14.7-fold higher levels than control rats. Within hours ZR reduced COX-2 overexpression to threefold that in control rats and reversed the hyperplastic phenotypes. The esophagus of ZD rats treated with celecoxib or indomethacin showed a reduction in cell proliferation and stimulation of apoptosis. NQO treatment resulted in greater incidence of lingual squamous cell carcinomas (74% versus 22%, difference = 52%, 95% confidence interval [CI] = 20% to 80%, P = .015) and greater tumor multiplicity (13.1 versus 4.3, difference = 8.8, 95% CI = 7.0 to 10.6, P = .018) in ZD than ZS rats. Of 23 NQO-treated ZD rats, 39% (9) and 61% (14) harbored esophageal and forestomach tumors, respectively, whereas none of the NQO-treated ZS rats did. Conclusions: COX-2 overexpression accompanies hyperplasia in ZD rats. Increased cell proliferation in NQO-treated ZD rats facilitates the development of tumors at multiple sites. The finding that zinc regulates COX-2 expression in vivo in an animal model may lead to prevention or therapeutic possibilities for upper aerodigestive tract cancer.
引用
收藏
页码:40 / 50
页数:11
相关论文
共 43 条
[21]   Differentially expressed genes execute zinc-induced apoptosis in precancerous esophageal epithelium of zinc-deficient rats [J].
Ishii, H ;
Vecchione, A ;
Furukawa, Y ;
Croce, CM ;
Huebner, K ;
Fong, LYY .
ONCOGENE, 2004, 23 (49) :8040-8048
[22]   Zink- und Vitamin-A-Mangel bei MundschleimhauterkrankungenZinc- and vitamin A-deficiency in patients with oral premalignancies [J].
C. Kleier ;
R. Werkmeister ;
U. Joos .
Mund-, Kiefer- und Gesichtschirurgie, 1998, 2 (6) :320-325
[23]   Oesophageal squamous cell neoplasia in head and neck cancer patients:: upregulation of COX-2 during carcinogenesis [J].
Maaser, K ;
Däubler, P ;
Barthel, B ;
Heine, B ;
von Lampe, B ;
Stein, H ;
Hoffmeister, B ;
Scherer, H ;
Scherübl, H .
BRITISH JOURNAL OF CANCER, 2003, 88 (08) :1217-1222
[24]  
Makuuchi Hiroyasu, 1996, Tokai Journal of Experimental and Clinical Medicine, V21, P139
[25]  
Mestre JR, 1997, CANCER RES, V57, P1081
[26]   COX-2 inhibitors: Cancer trials test new uses for pain drug [J].
Michalowski, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (04) :248-249
[27]  
Moore SR, 2000, ORAL DIS, V6, P75
[28]   Suppression of intestinal polyposis in Apc(Delta 716) knockout mice by inhibition of cyclooxygenase 2 (COX-2) [J].
Oshima, M ;
Dinchuk, JE ;
Kargman, SL ;
Oshima, H ;
Hancock, B ;
Kwong, E ;
Trzaskos, JM ;
Evans, JF ;
Taketo, MM .
CELL, 1996, 87 (05) :803-809
[29]   Estimating the world cancer burden: GLOBOCAN 2000 [J].
Parkin, DM ;
Bray, F ;
Ferlay, J ;
Pisani, P .
INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (02) :153-156
[30]   Zinc in cancer prevention [J].
Prasad, AS ;
Kucuk, O .
CANCER AND METASTASIS REVIEWS, 2002, 21 (3-4) :291-295